- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 517/00 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
Patent holdings for IPC class C07D 517/00
Total number of patents in this class: 38
10-year publication summary
|
0
|
0
|
3
|
0
|
0
|
2
|
2
|
1
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 507 |
3 |
| Allergan, Inc. | 2170 |
2 |
| Vertex Pharmaceuticals Incorporated | 1586 |
2 |
| China Pharmaceutical University | 357 |
2 |
| Merck Sharp & Dohme LLC | 3734 |
2 |
| Bristol-myers Squibb Company | 4725 |
1 |
| Boehringer Ingelheim International GmbH | 4502 |
1 |
| ExxonMobil Research And Engineering Company | 2433 |
1 |
| Merck Patent GmbH | 5725 |
1 |
| Amgen Inc. | 4418 |
1 |
| The Trustees of Columbia University in the City of New York | 3638 |
1 |
| Abbvie Inc. | 1844 |
1 |
| AbbVie Deutschland GmbH & Co. KG | 257 |
1 |
| Millennium Pharmaceuticals, Inc. | 430 |
1 |
| Purdue Research Foundation | 3908 |
1 |
| Biogen Idec MA Inc. | 155 |
1 |
| Contemporary Amperex Technology Co., Limited | 9818 |
1 |
| Indian Institute of Science | 351 |
1 |
| Medshine Discovery Inc. | 587 |
1 |
| MSD K. K. | 4 |
1 |
| Other owners | 12 |